| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.27 | 9e-13 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.33 | 1e-10 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.22 | 3e-10 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.23 | 5e-10 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | 0.21 | 3e-09 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.2 | 1e-08 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | 0.23 | 1e-08 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | 0.21 | 1e-08 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.19 | 2e-08 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.22 | 5e-08 |